Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inna V Dolzhikova

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
International Journal of Molecular Sciences|March 13, 2025
Real-Time PCR-Based Test as a Research Tool for the Retrospective Detection and Identification of SARS-CoV-2 Variants of Concern in a SampleValeria O Makarova, Artem Shelkov, Anna Iliukhina, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBDDenis E Kolesov, Maria V Sinegubova, Lutsia K Dayanova, et al.
Plos One|May 18, 2016
Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune ResponsesAmir I Tukhvatulin, Alina S Dzharullaeva, Natalia M Tukhvatulina, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2022
Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light VaccineAlexey A Komissarov, Inna V Dolzhikova, Grigory A Efimov, et al.
Human Vaccines & Immunotherapeutics|August 1, 2022
SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical caseOlgo A Mukhina, Daria S Fomina, Vasiliy V Parshin, et al.
Plos One|March 11, 2016
Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominisDaria A Burmistrova, Sergey V Tillib, Dmitry V Shcheblyakov, et al.
Biochemistry. Biokhimiia|September 1, 2024
Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding DomainNikolai N Sluchanko, Dmitry V Shcheblyakov, Larisa A Varfolomeeva, et al.
Microorganisms|November 4, 2020
Integrated into Environmental Biofilm <i>Chromobacterium vaccinii</i> Survives Winter with Support of Bacterial CommunityDaria A Egorova, Olga L Voronina, Andrey I Solovyev, et al.
Vaccines|October 28, 2023
In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1Andrei A Pochtovyi, Daria D Kustova, Andrei E Siniavin, et al.
Bio-Protocol|December 29, 2025
An Ex Vivo Lung Histoculture Model for Studying Pulmonary Infection and Immune Response With SARS-CoV-2 as an Example of RNA VirusElena V Maryukhnich, Daria M Potashnikova, Daria A Vorobyeva, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
International Journal of Molecular Sciences|March 13, 2025
Real-Time PCR-Based Test as a Research Tool for the Retrospective Detection and Identification of SARS-CoV-2 Variants of Concern in a SampleValeria O Makarova, Artem Shelkov, Anna Iliukhina, et al.
Diagnostics (Basel, Switzerland)|February 25, 2022
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBDDenis E Kolesov, Maria V Sinegubova, Lutsia K Dayanova, et al.
Plos One|May 18, 2016
Powerful Complex Immunoadjuvant Based on Synergistic Effect of Combined TLR4 and NOD2 Activation Significantly Enhances Magnitude of Humoral and Cellular Adaptive Immune ResponsesAmir I Tukhvatulin, Alina S Dzharullaeva, Natalia M Tukhvatulina, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 1, 2022
Boosting of the SARS-CoV-2-Specific Immune Response after Vaccination with Single-Dose Sputnik Light VaccineAlexey A Komissarov, Inna V Dolzhikova, Grigory A Efimov, et al.
Human Vaccines & Immunotherapeutics|August 1, 2022
SARS-CoV-2 evolution in a patient with secondary B-cell immunodeficiency: A clinical caseOlgo A Mukhina, Daria S Fomina, Vasiliy V Parshin, et al.
Plos One|March 11, 2016
Genetic Passive Immunization with Adenoviral Vector Expressing Chimeric Nanobody-Fc Molecules as Therapy for Genital Infection Caused by Mycoplasma hominisDaria A Burmistrova, Sergey V Tillib, Dmitry V Shcheblyakov, et al.
Biochemistry. Biokhimiia|September 1, 2024
Structural Basis for Evasion of New SARS-CoV-2 Variants from the Potent Virus-Neutralizing Nanobody Targeting the S-Protein Receptor-Binding DomainNikolai N Sluchanko, Dmitry V Shcheblyakov, Larisa A Varfolomeeva, et al.
Microorganisms|November 4, 2020
Integrated into Environmental Biofilm <i>Chromobacterium vaccinii</i> Survives Winter with Support of Bacterial CommunityDaria A Egorova, Olga L Voronina, Andrey I Solovyev, et al.
Vaccines|October 28, 2023
In Vitro Efficacy of Antivirals and Monoclonal Antibodies against SARS-CoV-2 Omicron Lineages XBB.1.9.1, XBB.1.9.3, XBB.1.5, XBB.1.16, XBB.2.4, BQ.1.1.45, CH.1.1, and CL.1Andrei A Pochtovyi, Daria D Kustova, Andrei E Siniavin, et al.
Bio-Protocol|December 29, 2025
An Ex Vivo Lung Histoculture Model for Studying Pulmonary Infection and Immune Response With SARS-CoV-2 as an Example of RNA VirusElena V Maryukhnich, Daria M Potashnikova, Daria A Vorobyeva, et al.
Pageof 3